abstract |
FIELD: pharmaceutical industry. n SUBSTANCE: invention relates to compounds of formula (I), their pharmaceutically acceptable salts or stereoisomers as well as pharmaceutical compositions containing them, and their use in the manufacture of medicaments for treatment of cancer. n EFFECT: new compounds have been obtained that act as inhibitors of CDK4/6 and are useful in treatment of mediated diseases. n 13 cl, 7 tbl, 36 ex |